Advanced Ovarian Cancer: Platinum resistant, Advanced Ovarian Cancer: Platinum sensitive
A Phase 2 study to evaluate the safety and efficacy of EP0057 in combination with olaparib in advanced ovarian cancer patients.
Cancer Types: GYN, Ovarian
Lines of Therapy: 2nd Line Metastatic, 3rd Line+ Metastatic